How many insider declarations has Perry Matthew d filed?

Perry Matthew d has filed 4 public insider declarations with SEC (Form 4).

What is Perry Matthew d's role?

Perry Matthew d's reported role is not specified by the regulator across the filings.

Which companies does Perry Matthew d report trades for?

Perry Matthew d reports trades for 3 companies, including CTI Biopharma CORP.

← Executives ★ Sign in to follow

PM

Perry Matthew d

·SEC (Form 4)

CTI Biopharma CORP XOMA Corp XOMA Royalty Corp

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Perry Matthew d. Insider active across 3 companies, notably CTI Biopharma CORP. Cumulatively, 4 filings have been published. History available since 26 June 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Perry Matthew d

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

CTI Biopharma CORP (US)XOMA Corp (US)XOMA Royalty Corp (US)

Declarations4 total

●

PERRY MATTHEW D

DirectorExecutives14 Jul 2026XOMA Royalty Corp

12SEC ↗

24,138 sharesCommon StockSEC:0001193125-26-303721:0

◆

PERRY MATTHEW D

DirectorExecutives21 May 2025XOMA Royalty Corp

0SEC ↗

5,971 shares0Common StockSEC:0001214659-25-008321:0

◆

PERRY MATTHEW D

DirectorExecutives15 May 2024XOMA Corp

0SEC ↗

6,070 shares0Common StockSEC:0001214659-24-009518:0

●

PERRY MATTHEW D

DirectorExecutives26 Jun 2023CTI Biopharma CORP

$392,56519SEC ↗

43,139 shares@ US$9.10100.0% of flowCommon StockSEC:0000899243-23-016484:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

PM

Perry Matthew d

·SEC (Form 4)

CTI Biopharma CORP XOMA Corp XOMA Royalty Corp

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Perry Matthew d. Insider active across 3 companies, notably CTI Biopharma CORP. Cumulatively, 4 filings have been published. History available since 26 June 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.